H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Passive immummization can offer instant, short-term fortification against infectious agents

Passive immummization can offer instant, short-term fortification against infectious agents

COVID-19 may contribute to exponential growth of Parkinson's disease in future

COVID-19 may contribute to exponential growth of Parkinson's disease in future

Expanding sick leave protection is crucial during the COVID-19 crisis

Expanding sick leave protection is crucial during the COVID-19 crisis

Southwest CEO’s boast about airplanes’ low COVID risk flies by key concerns

Southwest CEO’s boast about airplanes’ low COVID risk flies by key concerns

10,000 liters of NaOClean Asia's disinfectant solution to be donated to nursing homes, churches

10,000 liters of NaOClean Asia's disinfectant solution to be donated to nursing homes, churches

Italy develops vaccine candidate that neutralizes SARS-CoV-2 in mice

Italy develops vaccine candidate that neutralizes SARS-CoV-2 in mice

Children are immune prepared for SARS-CoV-2

Children are immune prepared for SARS-CoV-2

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

Boston Children's Hospital launches two-pronged study of COVID-19 in children

Boston Children's Hospital launches two-pronged study of COVID-19 in children

Study looks into COVID‐19 preparedness in Michigan nursing homes

Study looks into COVID‐19 preparedness in Michigan nursing homes

Biden says OSHA isn’t doing enough to protect workers’ from COVID-19

Biden says OSHA isn’t doing enough to protect workers’ from COVID-19

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Penn Medicine launches convalescent plasma therapy trial for COVID-19 patients

Scientists estimate fatality ratio across full spectrum of COVID-19 disease

Scientists estimate fatality ratio across full spectrum of COVID-19 disease

COPD lungs inundated by abnormal stem cells, research finds

COPD lungs inundated by abnormal stem cells, research finds

China with the world: COVID-19 experts dialogues - the 4th talk transcript

China with the world: COVID-19 experts dialogues - the 4th talk transcript

A desperate scramble as COVID-19 families vie for access to plasma therapy

A desperate scramble as COVID-19 families vie for access to plasma therapy

Missing COVID-19 antibodies suggest mystery immune response

Missing COVID-19 antibodies suggest mystery immune response

Huge asymptomatic pool of coronavirus infected worldwide, say researchers

Huge asymptomatic pool of coronavirus infected worldwide, say researchers

How do viruses mutate and jump to humans?

How do viruses mutate and jump to humans?

Tiger with SARS-CoV-2 infection demostrates reverse zoonosis

Tiger with SARS-CoV-2 infection demostrates reverse zoonosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.